Literature DB >> 11897476

Epileptiform abnormalities in children with attention-deficit-hyperactivity disorder.

Lawrence P Richer1, Michael I Shevell, Bernard R Rosenblatt.   

Abstract

The proportion of children with attention-deficit-hyperactivity disorder and epileptiform abnormalities is compared with an historic control group of normal school-aged children. The medical records of 655 children 5-16 years of age referred to a single pediatric neurologist (M.S.) from January 1991 to December 1999 with school problems, behavior problems, or hyperactivity were retrospectively reviewed. Clinical criteria for attention-deficit-hyperactivity disorder were satisfied in 476 of these children. An electroencephalogram was obtained from 347 patients and coded as epileptiform in 6.1 +/- 1.3%, which is significantly higher (chi-square test, P < 0.025) than the prevalence rate of 3.5 +/- 0.6% observed in a study of 3,726 normal school-aged children. The epileptiform abnormality was present only with activation procedures in six of our patients (hyperventilation [n = 2] and photic stimulation [n = 4]). Only three of the 21 children with epileptiform abnormalities developed a seizure disorder in our cohort. We conclude that the prevalence rate of epileptiform abnormalities is greater in children with attention-deficit-hyperactivity disorder compared with that observed in normal school-aged children when hyperventilation and photic stimulation are used. However, the clinical utility of routine electroencephalography in the diagnosis of a comorbid seizure disorder in children with attention-deficit-hyperactivity disorder is limited.

Entities:  

Mesh:

Year:  2002        PMID: 11897476     DOI: 10.1016/s0887-8994(01)00370-8

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  19 in total

Review 1.  Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.

Authors:  M Tan; R Appleton
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

2.  Electrical, molecular and behavioral effects of interictal spiking in the rat.

Authors:  Daniel T Barkmeier; Danielle Senador; Karine Leclercq; Darshan Pai; Jing Hua; Nash N Boutros; Rafal M Kaminski; Jeffrey A Loeb
Journal:  Neurobiol Dis       Date:  2012-03-26       Impact factor: 5.996

3.  Attention deficit hyperactivity disorder (ADHD) in children with epilepsy.

Authors:  Man Wang; Qin Zhao; Huicong Kang; Suiqiang Zhu
Journal:  Ir J Med Sci       Date:  2019-06-11       Impact factor: 1.568

Review 4.  Diving and attention deficit hyperactivity disorder.

Authors:  Abraham L Querido; Robert A van Hulst
Journal:  Diving Hyperb Med       Date:  2019-03-31       Impact factor: 0.887

5.  Attention deficit and hyperactivity disorder among school children in Kinshasa, Democratic Republic of Congo.

Authors:  E Kashala; T Tylleskar; I Elgen; K T Kayembe; K Sommerfelt
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 6.  An animal model to study the clinical significance of interictal spiking.

Authors:  D T Barkmeier; J A Loeb
Journal:  Clin EEG Neurosci       Date:  2009-10       Impact factor: 1.843

7.  EEG and MRI findings and their relation with intellectual disability in pervasive developmental disorders.

Authors:  Ozlem Unal; Ozlem Ozcan; Ozgür Oner; Melda Akcakin; Ayla Aysev; Gülhis Deda
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

8.  Maturation-dependent behavioral deficits and cell injury in developing animals during the subacute postictal period.

Authors:  Lauren M Mlsna; Sookyong Koh
Journal:  Epilepsy Behav       Date:  2013-08-23       Impact factor: 2.937

9.  Modulation of locomotor behaviors by location-specific epileptic spiking and seizures.

Authors:  Joseph R Geraghty; Danielle Senador; Biswajit Maharathi; Mitchell P Butler; Deepshika Sudhakar; Rachael A Smith; Yichao Wu; Jeffrey A Loeb
Journal:  Epilepsy Behav       Date:  2020-12-10       Impact factor: 2.937

Review 10.  Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.

Authors:  Beth A Leeman-Markowski; Jesse Adams; Samantha P Martin; Orrin Devinsky; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2020-12-24       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.